Brief: Irlab Q4 Operating Loss Widens To SEK 35.7 Mln

IRLAB Therapeutics AB

07/02/2024 06:16

Feb 7 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * FINANCIAL HIGHLIGHTS IN Q4
    * Q4 NET SALES: SEK -1.2M (SEK 12.2M)
    * Q4 OPERATING PROFIT: SEK -35.7M (SEK -33.1M)

Source text for Eikon:  ID:nMFNc073HD 
Further company coverage:  IRLABa.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))